Struggling with alcohol cravings? Naltrexone targets the brain's reward center to minimize drinking urges and reduce harmful binge-drinking behaviors.

South Carolina reported 26 new measles cases since Friday, bringing the total number of cases in the latest outbreak to 211. Some people were exposed in schools or churches.

New obesity criteria that add waist and body fat measures to BMI could classify nearly 70% of U.S. adults as obese, according to a new study.

A new study finds that sleep timing is linked to dementia risk, as people with weak circadian rhythms face a 2.5 times higher risk of developing cognitive decline.

Common OTC painkillers like ibuprofen may increase heart attack and stroke risk. Learn which medications pose the greatest cardiovascular danger.

New York reports record flu hospitalizations and cases, with a rise of nearly 1,000 in a single week. Health experts urge immediate vaccination as a new variant spreads.

U.S. childhood immunization schedule reduced to 11 diseases from 18 under new CDC guidelines in major overhaul.

Elon Musk announces Neuralink brain implants will enter "high-volume" production by 2026, helping paralyzed patients control devices with thought.

Some cancers may not require immediate treatment, from prostate cancer to thyroid tumors. Medical experts share when "watchful waiting" may be the best approach.

Ditch doom-scrolling for an “analog bag." TikTok users are replacing phones with books, art and puzzles to build healthier, happier habits.

Researchers discover possible weakness in deadly hospital superbug C. auris that could lead to new treatments for the drug-resistant fungal infection.

First-ever fentanyl overdose prevention vaccine could save thousands of lives annually, with human trials beginning early 2026 after animal studies.

A new study reveals distinct patterns in buttock muscles linked to type 2 diabetes, offering new insights into metabolic health and detection.

First-ever fentanyl overdose prevention vaccine could save thousands of lives annually, with human trials beginning early 2026 after animal studies.